Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer

Authors:
  • PGPANTOPRAZOLE‐DUODENAL ULCER‐STUDY GROUP
    PANTOPRAZOLE‐DUODENAL ULCER‐STUDY GROUP

Abstract
SUMMARY: Background:Pantoprazole is a new substituted benzimidazole that blocks the H+/K+‐ATPase in the gastric mucosa and thus inhibits acid secretion.Methods: Efficacy and tolerability of pantoprazole (40 mg at breakfast) and ranitidine (300 mg at bedtime) in the treatment of uncomplicated acute duodenal ulcer were compared in a double‐blind, randomized multicentre trial.Results:Of 202 outpatients who entered the study, 185 terminated the treatment without violation of the protocol. After 2 weeks of treatment, healing rates (protocol correct) with pantoprazole and ranitidine were 81 and 53%, respectively (P> 0.001), the corresponding results after 4 weeks were 97 and 83% (P> 0.01). Pantoprazole was more effective with respect to symptom relief. Both treatments were well tolerated.Conclusion:Pantoprazole 40 mg at breakfast is superior to ranitidine 300 mg at bedtime in the short‐term treatment of acute, uncomplicated duodenal ulcer.

This publication has 16 references indexed in Scilit: